signal management
Including signal detection, validation, prioritization, and assessment
![Two men reviewing data on computer screen](https://www.propharmagroup.com/hubfs/Services%20Assets/pv/two-men-reviewing-data-on-computer-screen.webp)
![Two men reviewing data on computer screen](https://www.propharmagroup.com/hubfs/Services%20Assets/pv/two-men-reviewing-data-on-computer-screen.webp)
Signal Management Services
ProPharma has deep expertise across all signal detection and management activities, including validation, prioritization, and assessment using data from a wide range of sources that are relevant for signal detection for the individual product(s). We are also fully trained and experienced in the EudraVigilance Data Analysis System (EVDAS) functionality and can support MAHs to comply with their obligations for signal detection and management. We leverage our robust knowledge to select the most efficient and effective method(s) for each product that is compliant with legislative requirements.
ProPharma's simple but scalable model of signal detection and management allows clients to obtain the exact services necessary throughout the entire life cycle of their products.
Signal management is a critical process for the proactive and timely identification of potential new safety risks for medicinal products that require the utmost expertise. Signal management can be deployed throughout both the clinical development and post-marketing phases of the product lifecycle. Safety issues may affect the benefit-risk balance of the product, requiring updates to product labels and other steps that help protect patients from harm.
Signal Detection in Pharmacovigilance
Signal detection in pharmacovigilance is the systematic process of identifying and evaluating potential safety signals in the data relating to a pharmaceutical product. This process involves scrutinizing various data sources for previously unrecognized adverse events or changes in patterns of known adverse events, which might be caused by a medicine. This is vital to monitor and assure the safety of a pharmaceutical product throughout its life cycle.
Key Steps in Signal Management
-
Signal Detection: Identifying potential safety signals using various data sources such as adverse event databases, literature, and other data.
-
Signal Validation: Verifying the identified signals to ensure they are genuine and warrant further investigation.
-
Signal Confirmation: Ensuring that the identified signal is supported by robust, scientific evidence.
-
Signal Assessment: Analyzing the available data to evaluate the relationship between the medicinal product and the observed risk and providing recommendations for mitigating risk to patient safety.
-
Communication: Working with the Client to inform regulatory authorities, healthcare professionals, patients, and the public about the findings and any new safety measures or recommendations resulting from signals in the management procedure.
-
Documentation: Recording all activities, assessments, decisions, and communications for accountability and future reference.
Significance of Signal Management
![Man reviewing data on a computer montior](https://www.propharmagroup.com/hs-fs/hubfs/auditing-services.jpg?width=2000&height=1125&name=auditing-services.jpg)
-
Patient Safety: Ensures that any potential safety concerns with pharmaceutical products are identified and managed to safeguard patients.
-
Regulatory Compliance: Ensures that regulatory requirements for monitoring and ensuring product safety are met.
-
Informed Decision Making: Helps healthcare professionals and patients make informed decisions about medicinal products.
-
Risk-Benefit Balance: Ensures that the benefits of a pharmaceutical product continue to outweigh its risks during the entire lifecycle.
How ProPharma Overcomes Signal Management Challenges
-
Data Quality: Defining robust strategies to analyze available data.
-
Timely Decision Making: Ensuring that decisions and communications are made in a timely manner to protect public health.
-
Global Consistency: Globally harmonized processes to collect, process, and assess data.
![Two healthcare professionals talking at a table](https://www.propharmagroup.com/hs-fs/hubfs/Services%20Assets/pv/two-healthcare-professionals-talking-at-a-table.webp?width=545&height=380&name=two-healthcare-professionals-talking-at-a-table.webp)
News & Insights
![What is the FSP Model in Clinical Research?](https://www.propharmagroup.com/hubfs/images/featured-images/health-care-worker-with-a-patient-in-a-home-ss-1813098529-1200x627.webp)
July 15, 2024
What is the FSP Model in Clinical Research?
Discover how the FSP model in clinical research offers flexible, cost-effective outsourcing for specific functions, enhancing drug discovery and trial efficiency.
July 11, 2024
Meet the Expert: Tariq Khan
Meet Tariq Khan, a Senior Pharmacovigilance Consultant at PV Alliance, sharing insights on client relationships, challenges in the industry, and personal interests outside of work. Learn how...
![ProPharma Receives 2024 CRO Leadership Award](https://www.propharmagroup.com/hubfs/blogs/press-releases/propharma-clinical-leader-cro-leadership-award.webp)
June 13, 2024
ProPharma Receives 2024 CRO Leadership Award
ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.
![Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device](https://www.propharmagroup.com/hubfs/CF%20Box%20Web%20featured%20image%20-%20%201%20Desktop%20%282%29.jpg)
May 2, 2024
Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device
ProPharma and PBL introduce Cell Factory Box for decentralized Cell & Gene Therapies manufacturing, reducing costs and improving patient access to life-saving treatments.
![ProPharma Receives 2024 CRO Leadership Award](https://www.propharmagroup.com/hubfs/blogs/press-releases/propharma-clinical-leader-cro-leadership-award.webp)
June 13, 2024
ProPharma Receives 2024 CRO Leadership Award
ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.
![EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist](https://www.propharmagroup.com/hubfs/michael-stomberg-EY-national-finalist-blog.png)
November 27, 2023
EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist
Ernst & Young announces Michael Stomberg as a finalized for Entrepreneur Of The Year® 2023 National Award to celebrate ambitious entrepreneurs.
![The Cost of Poor Project Management - ProPharma](https://www.propharmagroup.com/hubfs/Resources/Resources%20Thumbnails/Case%20Studies/the-cost-of-poor-project-management-case-study-thumbnail.webp)
June 10, 2022
The Cost of Poor Project Management
Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...
![Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma](https://www.propharmagroup.com/hubfs/Resources/Resources%20Thumbnails/Case%20Studies/case-study-gdp-compliance-thumbnail.webp)
August 31, 2022
Successfully Passing MHRA Inspections for Overseas Manufacturing Sites
ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...
News & Insights